AstraZeneca PLC (AZN)
AstraZeneca Market Cap : 599.03B for Feb. 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GSK Plc | 118.03B |
| Biodexa Pharmaceuticals Plc | 1.065M |
| Mereo BioPharma Group Plc | 64.51M |
| Amgen, Inc. | 196.52B |
| Regeneron Pharmaceuticals, Inc. | 79.80B |
Market Cap Related Metrics
| PE Ratio | 64.15 |
| PS Ratio | 10.38 |
| PEG Ratio | 1.435 |
| Price to Book Value | 13.05 |
| Price to Free Cash Flow | 61.10 |
| Price | 193.20 |
| Earnings Yield | 1.56% |
| PEGY Ratio | 1.383 |
| Operating PE Ratio | 47.46 |
| Normalized PE Ratio | 62.85 |